Provided by Tiger Fintech (Singapore) Pte. Ltd.

Alcon Inc.

89.61
-2.9800-3.22%
Post-market: 89.620.0100+0.01%17:03 EDT
Volume:1.83M
Turnover:165.62M
Market Cap:44.32B
PE:43.71
High:92.62
Open:92.57
Low:89.45
Close:92.59
Loading ...

Alcon Publishes Agenda for 2025 Annual General Meeting

Business Wire
·
32 mins ago

ALC Stock May Rise With the Introduction of PanOptix Pro in US

Zacks
·
Yesterday

Alcon Expands Leadership in IOL Innovation with Clareon PanOptix Pro, Delivering Best-in-Class Light Utilization and Less Light Scatter

Business Wire
·
02 Apr

UBS Sticks to Their Buy Rating for Alcon (ALC)

TIPRANKS
·
02 Apr

Alcon Is Maintained at Overweight by Keybanc

Dow Jones
·
31 Mar

3 Stocks to Watch in the Evolving Cell-Based Ophthalmic Therapy Space

Zacks
·
31 Mar

Oppenheimer Remains a Buy on Alcon (ALC)

TIPRANKS
·
28 Mar

Alcon (ALC) Soars 6.0%: Is Further Upside Left in the Stock?

Zacks
·
28 Mar

Alcon Is Maintained at Buy by Needham

Dow Jones
·
28 Mar

Alcon AG : Mizuho Raises Target Price to $120 From $115

THOMSON REUTERS
·
28 Mar

Needham Raises Price Target on Alcon to $110 From $107, Keeps Buy Rating

MT Newswires Live
·
28 Mar

Alcon Deal for Aurion Follows 2022 Investment, 2024 Lawsuit -- Market Talk

Dow Jones
·
27 Mar

Alcon Buys Majority Stake in Aurion to Advance Eye Disease Treatment

Dow Jones
·
27 Mar

Alcon Buys Majority Stake in Aurion Biotech

MT Newswires Live
·
27 Mar

Press Release: Alcon Acquires Majority Interest in Aurion Biotech, Inc. to Advance Innovative Cell Therapy for Corneal Endothelial Disease

Dow Jones
·
27 Mar

Morning Movers: 23andMe plummets after Chapter 11 proceedings and CEO exit

TipRanks
·
25 Mar

Alcon (ALC) Receives a Buy from Stifel Nicolaus

TIPRANKS
·
25 Mar

Alcon Gets CE Mark for Clareon Vivity Intraocular Lens

MT Newswires Live
·
25 Mar

Alcon Announces CE Mark Approval and Commercialization of Clareon Vivity IOL in Europe, Expanding Visual Possibilities

Business Wire
·
25 Mar

Alcon to Acquire Lensar for $430 Million

MT Newswires Live
·
24 Mar